Information expressed in the public domain by the Repharm Group is deceptive and contradictory
Today, on February 19, information has arrived in the public domain that the company from…
Today, on February 19, information has arrived in the public domain that the company from…
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Feb. 19, 2021 (GLOBE…
WOBURN, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
MIAMI, Feb. 19, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Chugai obtains exclusive development and marketing rights for AT-527 in Japan from Roche, who has…
CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company…
Partnerships will use Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody…
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…
SAN FRANCISCO, Feb. 19, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company…
Proposed U.S. EUA label update would enable the vaccine to be stored at -25°C to…
BOSTON, Feb. 19, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company…
Study Led by Gene Therapy Program at the University of Pennsylvania Published in Molecular Therapy…
SALT LAKE CITY, Feb. 19, 2021 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN) (along with…
SANTA MONICA, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or…
BOSTON, Feb. 19, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…